|
|
Magnetic resonance and ultrasound imaging as biomarkers for detection and monitoring of Parsonage-Turner Syndrome (PTS) |
| 1 R21 TR003033-01A1 |
SNEAG, DARRYL |
NCATS |
2020 |
|
|
Development and validation of clinical outcome assessments in LGMD2A |
| 1 R21 TR003184-01 |
JOHNSON, NICHOLAS ELWOOD |
NCATS |
2020 |
|
|
Metals Dysregulation, Brain Development, and Autism Spectrum Disorder |
| 1 R01 ES029511-01A1 |
VOLK, HEATHER E |
NIEHS |
2020 |
|
|
Toxicant Induced dysregulation of parvalbumin interneuron development and function |
| 1 R01 ES030109-01A1 |
PLAVICKI, JESSICA SUSAN |
NIEHS |
2020 |
|
|
A national birth cohort study of prenatal factors and neurodevelopmental psychiatric disorders |
| 1 R01 ES030966-01A1 |
BROWN, ALAN STEWART |
NIEHS |
2020 |
|
|
PCB-mediated dysbiosis of the gut microbiome: A missing link in PCB-mediated neurodevelopmental disorders? |
| 1 R01 ES031098-01 |
LEHMLER, HANS-JOACHIM |
NIEHS |
2020 |
|
|
Microbiome, Environment, and Parkinsons disease (MEP) PESTICIDE EXPOSURES AND THE GUT MICROBIOME IN PARKINSONS DISEASE |
| 1 R01 ES031106-01A1 |
RITZ, BEATE R |
NIEHS |
2020 |
|
|
Environmental chemical mixtures and metabolomics in autism spectrum disorder |
| 1 R01 ES031117-01 |
PETRICK, LAUREN |
NIEHS |
2020 |
|
|
ATP13A2 and Susceptibility to Neurodegeneration |
| 1 R01 ES031124-01 |
FLEMING, SHEILA |
NIEHS |
2020 |
|
|
Mechanisms associated with neuroprotection from Mn-induced neurotoxicity. |
| 1 R01 ES031282-01A1 |
LEE, EUN SOOK YU |
NIEHS |
2020 |
